藥物成份
共有 21678 個藥物成份
Cobase e Cortisol:\nM Streptavidin-coated microparticles (transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles 0.72 mg/mL; preservative.\nR1 Anti-cortisol-Ab~biotin (gray cap), 1 bottle, 9 mL: Biotinylated polyclonal anti-cortisol antibody (ovine) 90 ng/mL; MESb buffer 100 mmol/L, pH 6.0; preservative.\nR2 Cortisol-peptide~Ru(bpy) (black cap), 1 bottle, 9 mL: Cortisol derivative (synthetic), labeled with ruthenium complex 25 ng/mL; danazol 20 μg/mL; MES buffer 100 mmol/L, pH 6.0; preservative.\n\nCobase e Cortisol CalSet:\n• CORT Cal1: 2 bottles, each for 1.0 mL of calibrator 1\n• CORT Cal2: 2 bottles, each for 1.0 mL of calibrator 2\nCortisol (synthetic) in two concentration ranges (approx. 12.5 nmol/L or\n0.45 μg/dL and approx. 1000 nmol/L or 36 μg/dL) in a human serum matrix.\n
Column:3-micron Variant Assay column. Resin bound to a silica gel support.HBA2/F Controls: 2 vials,3 sets. Whole blood hemolysates containing hemoglobins A2 and F.HEMOGLOBIN F,A,S,C CONTROL: 6 vials, whole blood hemolysates containing hemoglobins F,A,S, C.Mobile Phase 1: 3.8L, 0.02 molar Bis-Tris and 0.002 molar KCNMobile Phase 2: 3.8L, 0.02 molar Bis-Tris and 0.002 molar KCN
Combur10Test M:Each test contains per 1 cm2 test patch area the following:Specific gravity: Ethyleneneglycol-bis(diaminoethylether)tetraacetic acid 182.8μg; bromthymol blue 36μg. PH: Bromthymolblue 13.9μg; methyl red 1.2μg; phenolphthalein 8.6μg. Leukocytes: Indoxylcarbonic acid ester 15.5μg; methoxymorpholinobenzene diazonium salt 5.5μg. Nitrite: 3-hydroxy-1,2,3,4-tetrahydro-7,8-benzoquinoline 33.5μg; sulfanilamide 29.1μg.Protein:3′,3〞,5′,5〞-tetrachlorophenol-3,4,5,6-tetrabromosulfophthalein 13.9μg.Glucose:3,3′,5.5′-tetramethylbenzidine 103.5μg; GOD 6 U, POD 35 U.Ketone bodies: Sodium nitroprusside 157.2μg.Urobilinogen: 4-methoxybenzene-diazonium-tetrafluoroborate 67.7μg.Bilirubin: 2,6-dichlorobenzene-diazonium-tetrafluoroborate 16.7 μg.Blood: 3,3′,5,5′-tetramethylbenzidine 52.8 μg; 2,5-dimethyl-2,5-dimethyl-2,5-dihydroperoxyhexane 297.2 μg.
Composition of the strip: 2-nitrophenyl-βD-galactopyranoside, D-glucose, L-arabinose, L-lysine, L-ornithine, trisodium citrate, sodium thiosulfate, urea, L-tryptophane, L-tryptophane, oxidase and Glu tube.
Composition of the strip: D-GALactose, Cycloheximide(ACTidione), D-SACcharose (sucrose), N-Acetyl-Glucosamine, LacTic acid, L-ARAbinose, D-CELlobiose, D-RAFfinose, D-MALtose, D-TREhalose, potassium 2-ketoGluconate, Methyl-xD-Glucopyranoside, D-MANnitol, D-LACtose (bovine origin), INOsitol, D-SORbitol, D-XYLose, D-RIBose, GLYcerol, L-RHAmnose, PaLatinosE, ERYthritol, D-MELibiose, sodium GlucuRonaTe, D-MeLeZitose, potassium GlucoNaTe, levulinic acid (LeVulinTe), D-GLUose, L-SorBosE, GlucosamiNe, ESCulin, ferric citrate.
Composition of the strip: L-arginine, resorufin-βD-glucopyranoside, resorufin-βD-galactopyranoside, resorufin-βD-glucuronide, 4-nitrophenyl-αD-galactopyranoside, 4-nitrophenyl-βD-galactopyranoside-2-CHA, D-ribose, D-mannitol, D-sorbitol, D-lactose (bovine origin), D-trehalose, D-raffinose, D-saccharose (sucrose), L-arabinose, D-arabitol, αcyclodextrin, Sodium pyruvate, L-alanyl-L-phenylalanyl-L-proline-β-naphthylamide, 2-naphthyl-βD-galactopyranoside, pyroglutamic acid-β-naphthylamide, 6-bromo-2-naphthyl-N-acetyl-βD-glucosamide, L-glycyl-L-tryptophan-β-naphthylamide, Sodium hippurate, glycogen, pullulan, D-maltose, D-melibiose, D-melezitose, methyl-βD-glucopyranoside, D-tagatose, 4-nitrophenyl-βD-mannopyranoside, and urea.
CompositionPAI Standard S1 (human), lyophilized: 0.0 U/mL PAIPAI Standard S2 (human), lyophilized: 5 to 7 U/mL PAI (exact concentration information: see vial lable)PAI Control Plasma (human), lyophilized: 2.5 to 4.0 U/mL PAIUrokinase Reagent, lyophilized; concentration in the working solution: 5 IU/mL urokinase (human), Tris (100 mmol/L), pH8.4Plasminogen Reagent: lyophilized; concentration in the working solution: 15 CTA U/mL plasminogen (human), Tris (100 mmol/L), pH8.4Oxidant, lyophilize; chloramines T, concentration in the working solution: 1.8 g/LPlasmin Substrate, lyophilized; concentration in the working solution: HD-Norvaly-cyclohexyl-ananyl-lysyl-p-nitroanilide (HD-Nva-CHA-Lys-pNA) 0.6 mmol/LSubstrate Working Solution; NaCl (35 g/L), Tris (50 mmol/L), pH 8.4
Conjugate:Mouse monoclonal antibodies to Toxoplasma gondii conjugated to an isoluminol derivative, non-specific IgG (mouse monoclonal), foetal calf serum, BSA, phosphate buffer, preservatives, an inert red dye.Negative control:Human serum/plasma without Toxoplasma gondii IgM antibodies, stabilized in PBS buffer, BSA, preservatives.Positive control:Human serum/plasma containing Toxoplasma gondii IgM antibodies, stabilized in PBS buffer, BSA, preservatives, an inert yellow dye.